Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?
James KiharaPrincipal Accounting Officer2023-09-152,000$25.88
Mark C. SchneyerEVP Chief Financial Officer2023-08-2110,000$29.00
Stephen DavisCEO2023-07-14100,000$30.04
Stephen DavisCEO2023-07-14100,000$20.77
Stephen DavisCEO2023-07-1255,104$25.05
Stephen DavisCEO2023-07-1116,498$25.00
James KiharaPrincipal Accounting Officer2023-06-152,000$24.15
Laura BregeDirector2023-06-124,500$24.87
Mark C. SchneyerEVP Chief Financial Officer2023-06-08974$25.02
Baker Bros Advisors LPDirector2023-05-2428,878$25.51

1 of 6

ACAD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?
Baker Bros Advisors LP26.18%42,864,612$922.88MInstitution
Baker Bros Advisors LP24.08%39,433,853$849.01MInsider
Baker Brothers Life Sciences LP8.69%14,229,612$306.36MInsider
Vanguard Group Inc8.46%13,854,846$298.29MInstitution
Blackrock Inc6.13%10,039,501$216.15MInstitution
Rtw Investments LP5.98%9,783,249$210.63MInstitution
Price T Rowe Associates Inc3.67%6,013,914$129.48MInstitution
Ecor1 Capital LLC3.66%5,991,479$129.00MInstitution
State Street Corp3.31%5,420,318$116.70MInstitution
Fmr LLC3.25%5,321,237$114.57MInstitution

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD71.05%28.95%Net BuyingNet Selling
CERE25.82%74.18%Net SellingNet Buying
FOLD65.52%34.48%Net SellingNet Selling
AXSM69.64%30.36%Net SellingNet Selling
MLTX78.68%21.32%Net Buying

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 96.29% institutional shareholders, 39.23% Acadia Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.43M shares representing 24.08% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $821.80M.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.